ABSI Aug 2024 5.000 put
- GlobeNewswire
Absci to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit
VANCOUVER, Wash. and NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Morgan Stanley 3rd Annual Life Sciences AI Summit on June 26-27 in New York, NY. Interested parties may contact their Morgan Stanley representative to request registration details for this live event. About Absci Absci is a data-first generative AI drug creation company that combines
- GlobeNewswire
Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
VANCOUVER, Wash. and NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL. Absci management is scheduled to present on Monday, June 10th at 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time). Interested parties may access a live and archived webcast on the company’s investor relations website
- GuruFocus.com
Absci Corp (ABSI) Q1 2024 Earnings Call Transcript Highlights: Strategic Advancements and ...
Explore key financial outcomes, strategic partnerships, and innovative developments from Absci Corp's first quarter of 2024.
